Forget a cash ISA! I’d rather pick up 6%+ from FTSE 100 dividend share Marks and Spencer

Marks and Spencer Group plc (LON: MKS) could deliver a higher total return than the FTSE 100 (INDEXFTSE: UKX) or a cash ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

The prospects for Marks & Spencer (LSE: MKS) may seem to be downbeat at present. The company is being beaten by nimbler, more flexible online rivals at a time when customer spending levels are at a low ebb. Therefore, its near-term financial prospects appear to be somewhat challenged.

In the long run, though, the retailer may offer turnaround potential. This could help to improve its dividend growth outlook. As such, it could be worth buying alongside a dividend growth stock which released positive news on Monday.

Improving outlook

The stock in question is animal healthcare specialist Eco Animal Health (LSE: EAH). It released interim results which showed a rise in sales of 9% to £31.7m. Its pre-tax profit moved 15% higher to £6.8m, while it was able to deliver a 25% increase in the interim dividend to 4p. Alongside this, it has declared an additional distribution of 3.5p per share.

During the period, the company recorded a recovery in Latin America. It also sought to invest in new routes to market and product development. Demand for Aivlosin continued to grow strongly, while new marketing authorisations were gained in Vietnam, with further authorisations expected in Canada, USA and South East Asia.

With Eco Animal Health forecast to post a rise in earnings of 45% in the current year, followed by additional growth of 11% next year, it could have scope to raise dividends. It has done so at an annualised rate of 22% over the last four years, which suggests that its current dividend yield of 2.4% could become increasingly impressive.

Uncertain future?

As mentioned, the near-term prospects for Marks & Spencer could be somewhat difficult. Brexit is dominating news headlines at present, and this situation may continue over the coming months. Consumers may therefore decide to hold off on certain purchases, or trade down to no-frills retailers which may offer better value for money. In other words, consumers may become less interested in convenience, quality or the shopping experience, and more interested in price.

Since Marks & Spencer is not a budget retailer, it may naturally experience a slowdown in sales growth. At the same time, it’s being forced to adapt to an increasingly flexible and nimble retail segment which is providing consumers with an extremely impressive level of service. Investment in this area should help the company to become more competitive, but it may take time for it to catch-up to more advanced rivals.

With a 6.7% dividend yield, Marks & Spencer could offer a sound income return in the near term. In the long run, its payout ratio of 72% appears to be affordable, while its investment in online may provide it with a growth catalyst. Therefore, its total return could be impressive in the long run, with it seeming to be a recovery stock at the present time.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Peter Stephens has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »